UNASNEMAB
UNII XB2155292Y

Substance Identification & Data

This profile provides standardized clinical and technical data for Unasnemab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XB2155292Y.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2379805-59-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

XB2155292Y

CAS Registry Number

2379805-59-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

UNASNEMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C179131

National Cancer Institute reference terminology for clinical and research data.

INN ID

11549

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-117

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Unasnemab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

UNASNEMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN REPULSIVE GUIDANCE MOLECULE RGMA) (HUMAN-MUS MUSCULUS CLONE RH116A3 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS CLONE RH116A3 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS RGMA (REPULSIVE GUIDANCE MOLECULE BMP CO-RECEPTOR A, RGM)), MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-446) (VH (MUS MUSCULUS IGHV6-6*01 (87%) -(IGHD) -IGHJ1*01 (90.9%)/HOMO SAPIENS IGHV3-49*04 (85%) -(IGHD) -IGHJ6*04 (100%)) CDR-IMGT (8.10.7) (26-33.51-60.99-105) (1- 116) -HOMO SAPIENS IGHG1*01 (100%), G1M17,1 (CH1 K120 (213) (117-214), HINGE 1-15 (215-229), CH2 (230-339), CH3 D12 (355), L14 (357) (340-444), CHS (445-446)) (117-446)), (219-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-12*01 (87.4%) -IGKJ4*01 (81.8%)) CDR-IMGT (6.3.9) (27-32.50-52.89-97) (1'-107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1 (153), V101 (191) (108'- 214')); DIMER (225-225'':228-228'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA

UNASNEMAB [INN]

UNASNEMAB [USAN]